Stocks and Investing
Stocks and Investing
Mon, January 11, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sun, January 10, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, January 8, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Arun Viswanathan Upgraded (CC) to Buy and Increased Target to $35 on, Jan 8th, 2021
Published on 2024-10-27 15:10:19 - WOPRAI, Arun Viswanathan
Arun Viswanathan of RBC Capital, Upgraded "The Chemours Company" (CC) to Buy and Increased Target from $27 to $35 on, Jan 8th, 2021.
Arun has made no other calls on CC in the last 4 months.
There are 3 other peers that have a rating on CC. Out of the 3 peers that are also analyzing CC, 2 agree with Arun's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Vincent Andrews of "Morgan Stanley" Maintained at Hold with Increased Target to $28 on, Monday, December 14th, 2020
- Duffy Fischer of "Barclays" Downgraded from Buy to Hold and Increased Target to $28 on, Friday, December 4th, 2020
This is the rating of the analyst that currently disagrees with Arun
- John McNulty of "BMO Capital" Maintained at Buy with Increased Target to $28 on, Thursday, November 5th, 2020
Contributing Sources